Evotec Completes Repayment Of EUR 140 M Acquisition Loan
EUR 140 M BRIDGE LOAN WAS DRAWN TO SECURE EVOTEC'S VALUE CHAIN EXPANSION BY SUCCESSFUL ACQUISITION OF APTUIT IN AUGUST...
user
Theralase(R) Releases 2018 Year End Audited Financial Statements
TORONTO, ON / ACCESSWIRE / April 17, 2019 /Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV: TLT) (OTCQB: TLTFF), a...
Stress in Legal Profession Misunderstood; Bellwether Research Paper Reveals
76% of respondents believe it is a major issueLondon, U.K., 17 April, 2019 – The latest Bellwether research paper titled,...
DECN Expands Talks Involving Its GenUltimate TBG System, Balances Potential and Competing Outcomes with Recent Intro to 2nd Interested Party
Company Receives 3rd Communique from FDA for Clearance of its GenChoice Test Strip, and at the Request of Agent Paragon,...
Emergent Health Corp. (EMGE: OTC Markets) – Important Shareholder Update
KING OF PRUSSIA, PA / ACCESSWIRE / April 17, 2019 / Emergent Health Corp. (the "Company") purpose of this Press...
ENDRA Life Sciences Granted U.S. Patent for Determining Fractional Fat Content of Tissue
Newly Issued Patent Strengthens Accuracy of TAEUS Fat Quantification Methodologies ANN ARBOR, MI / ACCESSWIRE / April 17, 2019 /...
EastWest Bioscience Incorporates US Company in Kentucky for US Operations and CBD Product Development
VANCOUVER, BC / ACCESSWIRE / April 17, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) is moving rapidly...
Avinger Announces Issuance of New U.S. Patent and Receives Notice of Allowance for Five Additional U.S. Patents
Extensive Intellectual Property Portfolio Now Includes 149 Patents and Applications REDWOOD CITY, CA / ACCESSWIRE / April 17, 2019 /...
ABMC Reports Fourth Quarter And Year End 2018 Results
KINDERHOOK, NY / ACCESSWIRE / April 16, 2019 / American Bio Medica Corporation (OTC PINK: ABMC) today announced financial results...
Footprints Behavioral Interventions Urges Oregonians to Get Involved During Autism Awareness Month
PORTLAND, OR / ACCESSWIRE / April 16, 2019 / For thousands of Oregonians and their families, a diagnosis of autism...
VITUS Prostata Center Offenbach: How Electricity Can Effectively Kill Cancer
OFFENBACH, GERMANY / ACCESSWIRE / April 16, 2019 / Prostate cancer is the most common cancer in men, affecting 25%...
Brighthaven Ventures LLC Awarded Over $46 Million in Judgments in Civil Claims against Islet Sciences, Inc. and John F. Steel IV
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 16, 2019 / Brighthaven Ventures LLC. ("BHV"), a wholly owned subsidiary of...
Virpax(R) Pharmaceuticals Licenses Molecular Envelope Technology (MET) Intranasal Formulation From Nanomerics Ltd.
Virpax® to Develop a Non-Opioid Molecular Envelope Technology (MET) Intranasal Formulation for the Management of Chronic Pain MALVERN, PA /...
Allysta Pharmaceuticals, Inc. Raises $15 Million in Series A Financing to Advance Novel Therapeutic for Dry Eye Disease
SAN MATEO, CA / ACCESSWIRE / April 16, 2019 / Allysta Pharmaceuticals, Inc. ("Allysta") today announced that they have completed...
Aytu BioScience Appoints Steven Boyd to the Company’s Board of Directors
ENGLEWOOD, CO / ACCESSWIRE / April 16, 2019 / Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on...
CEVEC Closes Major Financing Round To Further Expand And Commercialize Its Viral Vector Manufacturing Platform
Funding strengthens CEVEC's leading role in viral vector manufacturing technology CEVEC's technology allows for industrial scale manufacturing of AAV vectors...
Intellipharmaceutics Announces First Quarter 2019 Results
TORONTO, ON / ACCESSWIRE / April 15, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) (''Intellipharmaceutics'' or the...
AsclepiX Therapeutics Inc. Management to Present at the Solebury Trout Private Company Showcase
BALTIMORE, MD / ACCESSWIRE / April 15, 2019 / AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing vital new...
Avinger Announces Publication of Study Demonstrating Positive Clinical Outcomes for Patients Treated with Pantheris Prior to Antirestenotic Therapy
93% Primary Patency Rate and 100% Freedom from Target Lesion Revascularization at 12 Months REDWOOD CITY, CA / ACCESSWIRE /...
CTD Holdings Announces M. Flint Beal, MD Joins Scientific Advisory Board
Expansion brings expertise on Alzheimer's Disease and other neurodegenerative diseases to the SAB ALACHUA, FL / ACCESSWIRE / April 15,...